Eosinophilic oesophagitis: Latest intelligence

Clinical and Experimental Allergy

Volumn 41, Issue 5, 2011, Pages 630-639

  Schoepfer, A M ^a   Simon, D ^b   Straumann, A ^c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Chairman Swiss EoE Research Group   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID DERIVATIVE; CROMOGLYCATE DISODIUM; FLUTICASONE; IMMUNOGLOBULIN E; INFLIXIMAB; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MEPOLIZUMAB; MERCAPTOPURINE; POLLEN EXTRACT; PROTON PUMP INHIBITOR;

ALLERGIC RHINITIS; ALLERGY TEST; ASTHMA; ATOPIC DERMATITIS; CELL INFILTRATION; CLINICAL TRIAL (TOPIC); CORTICOSTEROID THERAPY; DIET THERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; DYSPHAGIA; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS CANDIDIASIS; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; HUMAN; IMMUNOTHERAPY; INFLAMMATION; NONHUMAN; OROPHARYNX CANDIDIASIS; PATCH TEST; PATHOGENESIS; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY;

EOSINOPHILIC ESOPHAGITIS; HUMANS; HYPERSENSITIVITY;

EID: 79954597524     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03739.x     Document Type: Review

References (94)

1. Attwood SE, Smyrk TC, Demeester TR, Jones JB. Oesophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993; 38:109-16.
2. Straumann A, Spichtin HP, Bernoulli R, Loosli J, Vögtlin J. Idiopathic eosinophilic oesophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz Med Wochenschr 1994; 124:1419-29.
3. Vitellas KM, Bennett WF, Bova JG, Johnston JC, Caldwell JH, Mayle JE. Idiopathic eosinophilic oesophagitis. Radiology 1993; 186:789-93.
4. Furuta GT, Liacouras CA, Collins MH et al. Eosinophilic oesophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133:1342-63.
5. Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H. Intraepithelial eosinophils: a new diagnostic criterion for reflux oesophagitis. Gastroenterology 1982; 83:818-23.
6. Coppi LC, Thomazzi SM, de Ayrizono ML et al. Comparative study of eosinophil chemotaxis, adhesion, and degranulation in vitro in ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2007; 13:211-8.
7. Ahmad M, Soetikno RM, Ahmed A. The differential diagnosis of eosinophilic oesophagitis. J Clin Gastroenterol 2000; 30:242-4.
8. Dellon ES, Aderoju A, Woosley JT, Sandler RS, Shaheen NJ. Variability in diagnostic criteria for eosinophilic oesophagitis: a systematic review. Am J Gastroenterol 2007; 102:2300-13.
9. Protheroe C, Woodruff SA, De Petris G et al. A novel histologic scoring system to evaluate mucosal biopsies form patients with eosinophilic oesophagitis. Clin Gastroenterol Hepatol 2009; 7:749-55, e11.
10. Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic oesophagitis. Am J Gastroenterol 2007; 102:1301-6 (review).
11. Schnyder B, Lugli S, Feng N et al. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Blood 1996; 87:4286-95.
12. Cheng L, Cao W, Behar J, Fiocchi C, Biancani P, Harnett KM. Acid-induced release of platelet-activating factor by human oesophageal mucosa induces inflammatory mediators in circular smooth muscle. J Pharmacol Exp Ther 2006; 319:117-26.
13. Nurko S, Rosen R, Furuta GT. Oesophageal dysmotility in children with eosinophilic oesophagitis: a study using prolonged oesophageal manometry. Am J Gastroenterol 2009; 104:3050-7.
14. Cheng L, Harnett KM, Cao W et al. Hydrogen peroxide reduces lower oesophageal sphincter tone in human oesophagitis. Gastroenterology 2005; 129:1675-85.
15. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted county, Minnesota. Gastroenterology 1997; 112:1448-56.
16. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic oesophagitis. N Engl J Med 2004; 351:940-1.
17. Straumann A, Simon HU. Eosinophilic oesophagitis: escalating epidemiology? J Allergy Clin Immunol 2005; 115:418-9.
18. Ngo P, Furuta GT, Antonioli DA, Fox VL. Eosinophils in the oesophagus - peptic or allergic eosinophilic oesophagitis? Case series of three patients with oesophageal eosinophilia. Am J Gastroenterol 2006; 101:1666-70.
19. Tobey NA, Hosseini SS, Argote CM, Dobrucali AM, Awayda MS, Orlando RC. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged oesophageal epithelium. Am J Gastroenterol 2004; 99:13-22.
20. Zhang X, Cheng E, Huo X et al. In oesophageal squamous epithelial cell lines from patients with eosinophilic oesophagitis (EoE), omeprazole blocks the stimulated secretion of eotaxin-3: a potential anti-inflammatory effect of omeprazole in EoE that is independent of acid inhibition. Gastroenterology 2010; 138 (Suppl. 1):5-122, A877.
21. Kottyan LC, Collier AR, Cao KH et al. Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner. Blood 2009; 114:2774-82.
22. Blanchard C, Stucke EM, Burwinkel K et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic oesophagitis. J Immunol 2010; 184:4033-41.
23. Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HU. Natural history of primary eosinophilic oesophagitis; a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 2003; 125:1660-9.
24. Remedios M, Campbell C, Jones DM, Kerlin P. Eosinophilic oesophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone proprionate. Gastrointest Endoc 2006; 63:3-12.
25. Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with oesophageal food impaction in adults. Gastrointest Endosc 2005; 61:795-801.
26. Croese J, Fairley SK, Masson JW et al. Clinical and endoscopic features of eosinophilic oesophagitis in adults. Gastrointest Endosc 2003; 58:516-22.
27. Teitelbaum JE, Fox VL, Twarog FJ et al. Eosinophilic oesophagitis in children; immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002; 122:1216-25.
28. Sant'Anna AM, Rolland S, Fournet JC, Yazbeck S, Drouin E. Eosinophilic oesophagitis in children: symptoms, histology, and pH probe results. J Pediatr Gastroenterol Nutr 2004; 39:373-7.
29. Orenstein SR, Shalaby TM, Di Lorenzo C et al. The spectrum of paediatric eosinophilic oesophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 2000; 95:1422-30.
30. Liacouras CA, Spergel JM, Ruchelli E et al. Eosinophilic oesophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005; 3:1198-206.
31. Straumann A, Bussmann C, Zuber M, Vannini S, Simon HU, Schoepfer A. Eosinophilic oesophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients. Clin Gastroenterol Hepatol 2008; 6:598-600.
32. Leslie C, Mews C, Charles A, Ravikumara M. Celiac disease and eosinophilic oesophagitis: a true association. J Pediatr Gastroenterol Nutr 2010; 50:397-9.
33. Lucendo AJ, Arias A, Pérez-Martinez I et al. Adult patients with eosinophilic oesophagitis do not show an increased frequency of the HLA-DQ2/DQ8 genotypes predisposing to celiac disease. Dig Dis Sci 2010. August 20 (epub).
34. Cherian S, Smith NM, Forbes DA. Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia. Arch Dis Child 2006; 91:1000-4.
35. Prasad GA, Alexander JA, Schleck CA et al. Epidemiology of eosinophilic oesophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2009; 7:1055-61.
36. DeBrosse CW, Collins M, Buckmeier Butz BK et al. Identification, epidemiology, and chronicity of paediatric oesophageal eosinophilia, 1982-1999. J Allergy Clin Immunol 2010; 126:112-9.
37. Straumann A, Rossi L, Simon HU, Heer P, Spichtin HP, Beglinger C. Fragility of the oesophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic oesophagitis? Gastrointest Endosc 2003; 57:407-12.
38. Yan BM, Shaffer EA. Primary eosinophilic disorders of the gastrointestinal tract. Gut 2009; 58:721-32.
39. Rothenberg ME, Mishra A, Brandt EB et al. Gastrointestinal eosinophils in health and disease. Adv Immunol 2001; 78:291-328.
40. Warren DJ, Moore MA. Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells. J Immunol 1988; 140:94-9.
41. Yamaguchi Y, Suda T, Suda J et al. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 1988; 167:43-56.
42. Mishra A, Hogan SP, Lee JJ et al. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest 1999; 103:1719-27.
43. Rothenberg ME, Luster AD, Lilly CM et al. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J Exp Med 1995; 181:1211-6.
44. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT et al. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996; 2:449-56.
45. Forssmann U, Uguccioni M, Loetscher P et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997; 185:2171-6.
46. Shinkai A, Yoshisue H, Koike M et al. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4 stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 1999; 163:1602-10.
47. Blanchard C, Wang N, Stringer KF et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic oesophagitis. J Clin Invest 2006; 116:536-47.
48. Matthews AN, Friend DS, Zimmermann N et al. Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci USA 1998; 95:6273-8.
49. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 1994; 94:427-38.
50. Mishra A, Wang M, Pemmaraju VR et al. Oesophageal remodeling develops as a consequence of tissue specific IL-5 induced eosinophilia. Gastroenterology 2008; 134:204-14.
51. Aceves SS, Newbury RO, Dohil R, Bastian JF, Broide DH. Oesophageal remodeling in paediatric eosinophilic oesophagitis. J Allergy Clin Immunol 2007; 119:206-12.
52. Aceves SS, Newbury RO, Chen D et al. Resolution of remodeling in eosinophilic oesophagitis correlates with epithelial response to topical corticosteroids. Allergy 2010; 65:109-16.
53. Straumann A, Conus S, Degen L et al. Budesonide is effective in adolescent and adult patients with active eosinophilic oesophagitis. Gastroenterology 2010; 139:1526-37.
54. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental oesophagitis. J Clin Invest 2001; 107:83-90.
55. Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic oesophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 2003; 125:1419-27.
56. Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopathic eosinophilic oesophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 2001; 108:954-61.
57. Pope SM, Brandt EB, Mishra A et al. IL-13 induces eosinophil recruitment into the lung by an IL-5-and eotaxin-dependent mechanism. J Allergy Clin Immunol 2001; 108:594-601.
58. Blanchard C, Mishra A, Saito-Akei H et al. Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clin Exp Allergy 2005; 35:1096-103.
59. Zuo L, Fulkerson PC, Finkelman FD et al. IL-13 induces oesophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway. J Immunol 2010; 185:660-9.
60. Neilsen CV, Bryce PJ. Interleukin-13 directly promotes oesophagus production of CCL11 and CCL24 and the migration of eosinophils. Clin Exp Allergy 2010; 40:427-34.
61. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. IL-5 promotes eosinophil trafficking to the oesophagus. J Immunol 2002; 168:2464-9.
62. Yamazaki K, Murray JA, Arora AS et al. Allergen-specific in vitro cytokine production in adult patients with eosinophilic oesophagitis. Dig Dis Sci 2006; 51:1934-41.
63. Simon D, Marti H, Heer P, Simon HU, Braathen LR, Straumann A. Eosinophilic oesophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol 2005; 115:1090-2.
64. Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA. The use of skin prick tests and patch tests to identify causative foods in eosinophilic oesophagitis. J Allergy Clin Immunol 2002; 109:363-8.
65. Spergel JM, Andrews T, Brown-Whitehorn TF et al. Treatment of eosinophilic oesophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 2005; 95:336-43.
66. Erwin EA, James HR, Gutekunst HM, Russo JM, Kelleher KJ, Platts-Mills TA. Serum IgE measurement and detection of food allergy in paediatric patients with eosinophilic oesophagitis. Ann Allergy Asthma Immunol 2010; 104:496-502.
67. Bachert C, Vignola AM, Gevaert P, Leynaert B, Van Cauwenberge P, Bousquet J. Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin N Am 2004; 24:19-43.
68. Bieber T. Atopic dermatitis. N Engl J Med 2008; 358:1483-94.
69. Kagalwalla AF, Sentongo TA, Ritz S et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic oesophagitis. Clin Gastroenterol Hepatol 2006; 4:1097-102.
70. Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic oesophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995; 109:1503-12.
71. Simon D, Straumann A, Wenk A, Spichtin H, Simon HU, Braathen LR. Eosinophilic oesophagitis in adults - no clinical relevance of wheat and rye sensitizations. Allergy 2006; 61:1480-3.
72. Spergel JM, Brown-Whitehorn T, Beausoleil JL, Shuker M, Liacouras CA. Predictive values for skin prick test and atopy patch test for eosinophilic oesophagitis. J Allergy Clin Immunol 2007; 119:509-11.
73. Francalanci P, De Angelis P, Minnei F et al. Eosinophilic oesophagitis and Barrett's oesophagus: an occasional association of an overlap disease? Oesophageal 'double trouble' in two children. Digestion 2008; 77:16-9.
74. Wolfsen HC, Hemminger LL, Achem SR. Eosinophilic oesophagitis and Barrett's oesophagus with dysplasia. Clin Gastroenterol Hepatol 2007; 5:A18.
75. Esposito S, Marinello D, Paracchini R, Guidali P, Oderda G. Long-term follow-up of symptoms and peripheral eosinophil counts in seven children with eosinophilic oesophagitis. J Pediatr Gastroenterol Nutr 2004; 38:452-6.
76. Konikoff MR, Blanchard C, Kirby C et al. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic oesophagitis. Clin Gastroenterol Hepatol 2006; 4:1328-36.
77. Bhattacharya B, Carlsten J, Sabo E et al. Increased expression of eotaxin-3 distinguishes between eosinophilic oesophagitis and gastroesophageal reflux disease. Hum Pathol 2007; 38:1744-53.
78. Kukuruzovic RH, Elliott EE, O'Loughlin EV, Markowitz JE. Non-surgical interventions for eosinophilic oesophagitis. Cochrane Database Syst Rev 2004; CD004065. Review.
79. Straumann A. The natural history and complications of eosinophilic oesophagitis. Gastrointest Endosc Clin N Am 2008; 18:99-118.
80. Peterson KA, Thomas KL, Emerson LL et al. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic oesophagitis. Dig Dis Sci 2010; 55:1313-9.
81. Liacouras CA, Wenner WJ, Brown K, Ruchelli E. Primary eosinophilic oesophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 1998; 26:380-5.
82. Faubion WA Jr, Perrault J, Burgart LJ, Zein NN, Clawson M, Freese DK. Treatment of eosinophilic oesophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 1998; 27:90-3.
83. Konikoff MR, Noel RJ, Blanchard C et al. A randomized double-blind, placebo-controlled trial of fluticasone proprionate for paediatric eosinophilic oesophagitis. Gastroenterology 2006; 131:1381-91.
84. Aceves SS, Bastian JF, Newbury RO, Dohil R. Oral viscous budesonide: a potential new therapy for eosinophilic oesophagitis in children. Am J Gastroenterol 2007; 102:1-9.
85. Schaefer ET, Fitzgerald JF, Molleston JP et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic oesophagitis: a randomized trial in children. Clin Gastroenterol Hepatol 2008; 6:165-73.
86. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999; 159:941-55.
87. Straumann A, Conus S, Degen L et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic oesophagitis. Clin Gastroenterol Hepatol 2011. January 28, epub.
88. Attwood SE, Lewis CJ, Bronder CS, Morris CD, Armstrong GR, Whittam J. Eosinophilic oesophagitis: a novel treatment using Montelukast. Gut 2003; 52:181-5.
89. Straumann A, Conus S, Grzonka P et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut 2010; 59:21-30.
90. Straumann A, Bussmann C, Conus S, Beglinger C, Simon HU. Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic oesophagitis. J Allergy Clin Immunol 2008; 122:425-7.
91. Netzer P, Gschossmann JM, Straumann A, Sendensky A, Weimann R, Schoepfer AM. Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission. Eur J Gastroenterol Hepatol 2007; 19:865-9.
92. Schoepfer AM, Gschossmann J, Scheurer U, Seibold F, Straumann A. Oesophageal strictures in adult eosinophilic oesophagitis: dilation is an effective and safe alternative after failure of topical corticosteroids. Endoscopy 2008; 40:161-4.
93. Schoepfer AM, Gonsalves N, Bussmann C et al. Oesophageal dilation in eosinophilic oesophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol 2010; 105:1062-70.
94. Dellon ES, Gibbs WB, Rubinas TC et al. Oesophageal dilation in eosinophilic oesophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc 2010; 71:706-12.